Wednesday, July 8, 2026
🇺🇸 FDA

biotech · Unresectable or metastatic conventional chondrosarcoma · Advanced or metastatic solid tumors · INBX

Inhibrx Biosciences

Inhibrx Biosciences patent portfolio — 35 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
San Diego, USA HQ
2010 Founded
114 Employees
Public company Type
INBX · NYSE Ticker
Company details
Status
Public
HQ
San Diego, USA
Founded
2010
Employees
114
Programs
10
Drugs
17
Patents
35
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

Inhibrx Biosciences patents

35 pharmaceutical patents indexed for Inhibrx Biosciences. 0 expire within 24 months.

Inhibrx Biosciences has 35 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

35 patents

Patent portfolio

  1. US 12365728

    DLL3 single domain antibodies and therapeutic compositions thereof

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12331126

    OX40-binding polypeptides and uses thereof

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12331132

    Multispecific polypeptide constructs having constrained CD3 binding and related methods and uses

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12227584

    Multivalent and multispecific OX40-binding fusion proteins

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12187804

    Multivalent and multispecific 41BB-binding proteins

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12084502

    CD33-binding polypeptides and uses thereof

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12043667

    CLEC12a binding polypeptides and uses thereof

    Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12012459

    OX40-binding polypeptides and uses thereof

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11976126

    Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11965017

    Serpin fusion polypeptides and methods of use thereof

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11919963

    CD123-binding polypeptides and uses thereof

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11866507

    Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11827691

    Serpin fusion polypeptides and methods of use thereof

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11566078

    PDL1-binding proteins

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11560428

    CD33-binding polypeptides and uses thereof

    Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11434297

    CD123-binding polypeptides and uses thereof

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11117972

    Multivalent and multispecific OX40-binding fusion proteins

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11117973

    Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11046752

    Serpin fusion polypeptides and methods of use thereof

    Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10844129

    Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acids

    Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10745466

    Type III secretion system targeting molecules

    Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10730929

    Serpin fusion polypeptides and methods of use thereof

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10723785

    Serpin fusion polypeptides and methods of use thereof

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10526397

    Non-immunogenic single domain antibodies

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10501551

    Multivalent and multispecific 41BB-binding fusion proteins

    Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10400029

    Serpin fusion polypeptides and methods of use thereof

    Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10344078

    Type III secretion system targeting molecules

    Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10308720

    Multivalent and multispecific DR5-binding fusion proteins

    Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10093742

    Multispecific GITR-binding fusion proteins and methods of use thereof

    Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9920109

    Serpin fusion polypeptides and methods of purification thereof

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9914765

    WAP domain fusion polypeptides and methods of use thereof

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9663575

    CD47 antibodies and methods of use thereof

    Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9045541

    CD47 antibodies and methods of use thereof

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8986688

    WAP domain fusion polypeptides and methods of use thereof

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8980266

    Serpin fusion polypeptides and methods of use thereof

    Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Inhibrx Biosciences have?

35 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Inhibrx Biosciences patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.